These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Corvus Pharmaceuticals' Soquelitinib shows promise for PTCL & more, but financial risks and competition raise concerns. Learn more about CRVS stock here.

Valbiotis unveils its annual financial statements and confirms its strategic and financial goals VALBIOTIS SA VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms ...

Under terms of the deal, Gubra will receive an initial $350 million payment and could earn up to $1.875 billion more in ...

In corporate R&D, both prototyping and commercialization are integral, yet the 52-hour workweek disrupts these workflows. By ...

Fresenius Kabi, an operating company of Fresenius, and Formycon AG, a leading, independent developer of high-quality ...

PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) ( the "Company" or "PetVivo”) an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics ...

ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial ...

Y-mAbs Therapeutics, Inc. (the "Company” or "Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results ...

The Swiss Technology Innovation Centre CSEM is investing in Switzerland's first drying room for battery development. From September 2025, this drying room at ...